Laboratorio Reig Jofre SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Laboratorio Reig Jofre SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014102
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratorio Reig Jofre SA (Reig Jofre) is a drug company that develops and manufactures medicinal products and nutritional supplements. The company’s product categories include specialized technology products, specialty therapeutic areas, and nutritional supplements and consumer healthcare. Its specialized technology products include antibiotics, injectable, and freeze-dried products. Reig Jofre develops products in liquid dosage forms, semi-solid forms, and solid oral dosage forms. The company offers services such as research and development, regulatory services, manufacturing, and licensing of dossiers. It conducts research in the areas of bioequivalence, clinical pharmacokinetics and bioavailability studies, drug interaction, preclinical pharmacokinetics, preclinical toxicokinetics, analysis and identification of metabolites. The company offers therapeutic products in the areas of dermatology, gynecology, and respiratory. Reig Jofre is headquartered in Sant Joan Despi, Spain.

Laboratorio Reig Jofre SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratorio Reig Jofre SA, Medical Devices Deals, 2011 to YTD 2017 9
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Laboratorio Reig Jofre Acquires Right for Heparin Sodium in Spain from Chiesi Espana 11
Laboratorio Reig Jofre Acquires Product Licenses from Dema UK for USD5.4 Million 12
Partnerships 13
Reig Jofre Enters Into Co-Development Agreement With Ojer Pharma For Nobactine 13
Merger 14
Laboratorio Reig Jofre Merges with Natraceutical 14
Licensing Agreements 15
Laboratorio Reig Jofre Enters into Licensing Agreement with Church & Dwight 15
Acquisition 16
Laboratorio Reig Jofre Acquires Remaining 50% Stake in Geadic Biotec for USD2.5 Million 16
Laboratorio Reig Jofre SA – Key Competitors 17
Laboratorio Reig Jofre SA – Key Employees 18
Laboratorio Reig Jofre SA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 20
Recent Developments 21
Financial Announcements 21
Aug 01, 2017: Reig Jofre: Results of First Half 2017 21
May 09, 2017: Reig Jofre: Results for the First Quarter of 2017 23
Jul 26, 2016: Reig Jofre: Results of First Half 2016 25
Product News 28
Sep 13, 2017: Reig Jofre Continues to Strengthen its Leadership in ENT with the Launch Of Otospray, 3E Ear Hygiene 28
Mar 23, 2017: Reig Jofre Starts Marketing of three New Injectable Products fror Hospitals 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Key Facts 2
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratorio Reig Jofre SA, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratorio Reig Jofre SA, Medical Devices Deals, 2011 to YTD 2017 9
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Laboratorio Reig Jofre Acquires Right for Heparin Sodium in Spain from Chiesi Espana 11
Laboratorio Reig Jofre Acquires Product Licenses from Dema UK for USD5.4 Million 12
Reig Jofre Enters Into Co-Development Agreement With Ojer Pharma For Nobactine 13
Laboratorio Reig Jofre Merges with Natraceutical 14
Laboratorio Reig Jofre Enters into Licensing Agreement with Church & Dwight 15
Laboratorio Reig Jofre Acquires Remaining 50% Stake in Geadic Biotec for USD2.5 Million 16
Laboratorio Reig Jofre SA, Key Competitors 17
Laboratorio Reig Jofre SA, Key Employees 18
Laboratorio Reig Jofre SA, Other Locations 19
Laboratorio Reig Jofre SA, Subsidiaries 19
Laboratorio Reig Jofre SA, Joint Venture 20

★海外企業調査レポート[Laboratorio Reig Jofre SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Telefonica UK Limited:企業の戦略的SWOT分析
    Telefonica UK Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Lietuvos Draudimas AB:企業の戦略的SWOT分析
    Lietuvos Draudimas AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • First Gen Corp (FGEN):電力:M&Aディール及び事業提携情報
    Summary First Gen Corp (First Gen) a subsidiary of First Philippine Holding Corporation is a producer and distributor of electric power. It undertakes activities such as power generation, power distribution, infrastructure, manufacturing, and property development. The company together with its subsi …
  • Hindustan Tin Works Limited:企業の戦略・SWOT・財務情報
    Hindustan Tin Works Limited - Strategy, SWOT and Corporate Finance Report Summary Hindustan Tin Works Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Diana S.A.S.:戦略・SWOT・企業財務分析
    Diana S.A.S. - Strategy, SWOT and Corporate Finance Report Summary Diana S.A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • KNM Group Bhd (KNM):石油・ガス:M&Aディール及び事業提携情報
    Summary KNM Group Bhd (KNM Group) is a manufacturer of custom designed process equipment's and modular systems. The company's product portfolio includes gas waste heat recovery systems, process and pressure vessels, quench coolers, scraped surface exchangers, heat transfer equipment, membrane techno …
  • Kadmon Holdings Inc (KDMN):製薬・医療:M&Aディール及び事業提携情報
    Summary Kadmon Holdings Inc (Kadmon) is an integrated biopharmaceutical company that discovers, develops and markets small molecules and biologics for autoimmune and fibrotic diseases, various types of cancer, and genetic diseases. The company’s pipeline encompasses investigational candidates for th …
  • China Sunshine Paper Holdings Company Limited:企業の戦略・SWOT・財務情報
    China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Deckers Outdoor Corporation (DECK):企業の財務・戦略的SWOT分析
    Deckers Outdoor Corporation (DECK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Ithaca Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Ithaca Energy Inc. (Ithaca), a subsidiary of Delek Group Ltd., is an oil and gas company, which explores for, develops, and produces oil and gas in the North Sea. It focuses on the appraisal and development of undeveloped discoveries and the exploitation of its existing UK producing asset po …
  • MOL Hungarian Oil and Gas Plc (MOL):企業の財務・戦略的SWOT分析
    MOL Hungarian Oil and Gas Plc (MOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Nasser S. Al –Hajri Corp:企業の戦略的SWOT分析
    Nasser S. Al –Hajri Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Dubai Electricity and Water Authority:企業の発電所・SWOT分析2018
    Dubai Electricity and Water Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Portola Pharmaceuticals Inc (PTLA):製薬・医療:M&Aディール及び事業提携情報
    Summary Portola Pharmaceuticals Inc (Portola Pharmaceuticals) is a biopharmaceutical company which conducts research to develop therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. The company's products portfolio include Betrixaban, an oral once-daily Factor Xa inh …
  • Bioactive Bone Substitutes Plc (BONEH):企業の製品パイプライン分析
    Summary Bioactive Bone Substitutes Plc (BBS) is a health technology company that manufactures biologically active medical device implants for orthopedic surgery. The company provides technology platforms, artebone, research and development, patents, and others. It offers artebone which is made up of …
  • Japan Pulp and Paper Co Ltd:戦略・SWOT・企業財務分析
    Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Memorial Health System:企業の戦略的SWOT分析
    Memorial Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • KitCheck Inc:医療機器:M&Aディール及び事業提携情報
    Summary KitCheck Inc (KitCheck) is a provider of automated hospital pharmacy kit processing and medication tracking software solution. The company’s Kit Check is an automated medication tray management system based on scalable cloud software platform uses RFID tags to track each medication that help …
  • SilverSun Technologies Inc (SSNT):企業の財務・戦略的SWOT分析
    Summary SilverSun Technologies Inc (SilverSun) is a technology company that offers transformational business technology solutions and services for manufacturers and distributors. The company’s ERP software products comprise ERP X3, MAS90 and MAS200. It offers network services such as 24/7 remote net …
  • Itamar Medical Ltd (ITMR):医療機器:M&Aディール及び事業提携情報
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, markets and sells diagnostic medical devices for the diagnosis and treatment of sleep apnea. The company’s products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction assessment tool fo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆